文献速递肺栓塞与肺血管病呼吸道感染间质性肺疾病

性别与性别因素在肺部疾病和睡眠障碍中的作用:最新综述第二部分

Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2.
PubMed 文献 · Chest · 2022-09-29

本综述总结了性别与性别因素对肺动脉高压、囊性纤维化(CF)与非CF支气管扩张、结节病、不宁腿综合征与失眠、危重症等疾病的影响,并讨论了妊娠对肺部疾病的作用以及性别对烟草使用和尼古丁使用障碍治疗的影响。综述强调性别差异影响疾病易感性、表现、诊断、病程及治疗反应,呼吁临床试验充分纳入药物基因组学因素,以推动精准医学。

要点

  • 女性肺动脉高压和结节病患病率更高,临床表现与男性不同。
  • 女性CF患者急性加重次数更多、死亡率更高,治疗反应可能存在性别差异。
  • 妊娠可影响肺部疾病的发生与病程,烟草使用及戒烟治疗也存在性别差异。

核心结论

  • 性别与性别因素影响多种肺部疾病和睡眠障碍的发病率、易感性、表现、诊断、病程及治疗反应。
  • 理解这些差异是实现精准医学的第一步。

研究设计与样本

  • 本文为最新综述的第二部分,聚焦特定肺部疾病和睡眠障碍的流行病学、疾病表现、危险因素和管理。
  • 综述了近期文献,并重点关注纳入性别差异的肺动脉高压、CF与非CF支气管扩张、结节病、不宁腿综合征与失眠、危重症相关指南。
  • 还总结了妊娠对肺部疾病的影响以及性别对烟草使用和尼古丁使用障碍治疗的影响。

主要发现

  • 女性肺动脉高压和结节病患病率更高。
  • 女性CF患者急性加重次数更多、死亡率更高;女性结节病患者疲劳更明显;女性戒烟更困难。
  • 妊娠可影响肺部疾病的发生与病程。
  • 治疗反应和药物安全性可能因性别而异,但药物基因组学因素在临床试验中常未充分涉及。
  • 女性生殖转变可影响肺/睡眠生物学和病理生物学,包括差异基因表达或器官发育。

临床怎么用

  • 临床应关注性别差异对肺部疾病和睡眠障碍的临床表现、病程及治疗反应的影响。
  • 在诊疗中考虑妊娠等女性特有生命阶段对肺部疾病的影响。
  • 针对烟草使用和尼古丁使用障碍的治疗需注意性别差异。

局限性

  • 药物基因组学因素在临床试验中常未充分涉及,可能影响性别特异性治疗证据的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is now ample evidence that differences in sex and gender contribute to the incidence, susceptibility, presentation, diagnosis, and clinical course of many lung diseases. Some conditions are more prevalent in women, such as pulmonary arterial hypertension and sarcoidosis. Some life stages-such as pregnancy-are unique to women and can affect the onset and course of lung disease. Clinical presentation may differ as well, such as the higher number of exacerbations experienced by women with cystic fibrosis (CF), more fatigue in women with sarcoidosis, and more difficulty in achieving smoking cessation. Outcomes such as mortality may be different as well, as indicated by the higher mortality in women with CF. In addition, response to therapy and medication safety may also differ by sex, and yet, pharmacogenomic factors are often not adequately addressed in clinical trials. Various aspects of lung/sleep biology and pathobiology are impacted by female sex and female reproductive transitions. Differential gene expression or organ development can be impacted by these biological differences. Understanding these differences is the first step in moving toward precision medicine for all patients. This article is the second part of a state-of-the-art review of specific effects of sex and gender focused on epidemiology, disease presentation, risk factors, and management of selected lung diseases. We review the more recent literature and focus on guidelines incorporating sex and gender differences in pulmonary hypertension, CF and non-CF bronchiectasis, sarcoidosis, restless legs syndrome and insomnia, and critical illness. We also provide a summary of the effects of pregnancy on lung diseases and discuss the impact of sex and gender on tobacco use and treatment of nicotine use disorder.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Sodhi A, Cox-Flaherty K, Greer MK, et al. Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2. Chest. 2022. PMID: 36183784. doi:10.1016/j.chest.2022.08.2240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。